Key Insights

Highlights

Treatment Research

2 treatments under study, led by Triple Inner Branched Arch Stentgraft

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1
Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Triple Inner Branched Arch Stentgraft1
  • Zipper Stentgraft Trial For Aortic Arch Dissection1

Active Sponsors

  • University Hospital Muenster1
  • Hangzhou Endonom Medtech Co., Ltd.1

Top Investigators

Related Conditions

  • Aortic Arch Aneurysm1
  • Aortic Arch1
  • Triple Branch1

Activity Timeline